Associated Papers
Brief biology and pathophysiology of Tekt bundles.
Yin J et al.
Cell Adhesion & Migration, 2025
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations.
Jiang YZ et al.
Breast Cancer Research and Treatment, 2021
Enriched variations in TEKT4 and breast cancer resistance to paclitaxel.
Jiang YZ et al.
Nature Communications, 2014
Select a paper to view details